275 related articles for article (PubMed ID: 28525213)
1. [Next generation sequencing].
Le Mercier M; D'Haene N; Rorive S; Degand C; De Nève N; Blanchard O; Salmon I
Rev Med Brux; 2016; 37(5):436-438. PubMed ID: 28525213
[TBL] [Abstract][Full Text] [Related]
2. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
Witt RL
Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
[TBL] [Abstract][Full Text] [Related]
3. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules.
Fuller MY; Mody D; Hull A; Pepper K; Hendrickson H; Olsen R
Arch Pathol Lab Med; 2018 Feb; 142(2):178-183. PubMed ID: 28537807
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of 167 Gene Expression Classifier (GEC) and ThyroSeq v2 Diagnostic Accuracy in the Preoperative Assessment of Indeterminate Thyroid Nodules: Bivariate/HROC Meta-analysis.
Borowczyk M; Szczepanek-Parulska E; Olejarz M; Więckowska B; Verburg FA; Dębicki S; Budny B; Janicka-Jedyńska M; Ziemnicka K; Ruchała M
Endocr Pathol; 2019 Mar; 30(1):8-15. PubMed ID: 30591992
[TBL] [Abstract][Full Text] [Related]
5. Thyroid cytology smear slides: An untapped resource for ThyroSeq testing.
Nikiforova MN; Lepe M; Tolino LA; Miller ME; Ohori NP; Wald AI; Landau MS; Kaya C; Malapelle U; Bellevicine C; Troncone G; Nikiforov YE; Baloch Z
Cancer Cytopathol; 2021 Jan; 129(1):33-42. PubMed ID: 32697051
[TBL] [Abstract][Full Text] [Related]
6. The Role of Molecular Testing for the Indeterminate Thyroid FNA.
Rossi ED; Pantanowitz L; Faquin WC
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31547603
[TBL] [Abstract][Full Text] [Related]
7. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
[No Abstract] [Full Text] [Related]
9. Ruling in or ruling out thyroid malignancy by molecular diagnostics of thyroid nodules.
Eszlinger M; Hegedüs L; Paschke R
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):545-57. PubMed ID: 25047205
[TBL] [Abstract][Full Text] [Related]
10. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules.
Nikiforov YE; Steward DL; Robinson-Smith TM; Haugen BR; Klopper JP; Zhu Z; Fagin JA; Falciglia M; Weber K; Nikiforova MN
J Clin Endocrinol Metab; 2009 Jun; 94(6):2092-8. PubMed ID: 19318445
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
[TBL] [Abstract][Full Text] [Related]
12. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
[TBL] [Abstract][Full Text] [Related]
13. Histology-based and cytology-based needle sampling for targeted next-generation sequencing in the indeterminate thyroid tumors.
Chen CN; Yang TL
Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3773-3781. PubMed ID: 37097467
[TBL] [Abstract][Full Text] [Related]
14. [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology].
Eszlinger M; Ruschenburg I; Paschke R
Dtsch Med Wochenschr; 2013 Oct; 138(40):2003-6. PubMed ID: 24065405
[No Abstract] [Full Text] [Related]
15. Plasma Cell-Free DNA to Differentiate Malignant from Benign Thyroid Nodules.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2262-e2270. PubMed ID: 33475693
[TBL] [Abstract][Full Text] [Related]
16. (99m)Tc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology.
Campennì A; Giovanella L; Siracusa M; Alibrandi A; Pignata SA; Giovinazzo S; Trimarchi F; Ruggeri RM; Baldari S
Thyroid; 2016 Aug; 26(8):1101-9. PubMed ID: 27266385
[TBL] [Abstract][Full Text] [Related]
17. Molecular Signature of Indeterminate Thyroid Lesions: Current Methods to Improve Fine Needle Aspiration Cytology (FNAC) Diagnosis.
Cantara S; Marzocchi C; Pilli T; Cardinale S; Forleo R; Castagna MG; Pacini F
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383480
[TBL] [Abstract][Full Text] [Related]
18. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
Keutgen XM; Filicori F; Fahey TJ
Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
[TBL] [Abstract][Full Text] [Related]
19. Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
Bellevicine C; Sgariglia R; Malapelle U; Vigliar E; Nacchio M; Ciancia G; Eszlinger M; Paschke R; Troncone G
Cancer Cytopathol; 2016 Nov; 124(11):776-784. PubMed ID: 27717198
[TBL] [Abstract][Full Text] [Related]
20. Benign call rate and molecular test result distribution of ThyroSeq v3.
Ohori NP; Landau MS; Carty SE; Yip L; LeBeau SO; Manroa P; Seethala RR; Schoedel KE; Nikiforova MN; Nikiforov YE
Cancer Cytopathol; 2019 Mar; 127(3):161-168. PubMed ID: 30561907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
